Aldevron - About the company
Aldevron is an acquired company based in Fargo (United States), founded in 1998. It operates as a Manufacturing plasmid DNA, RNA, proteins, and enzymes for genomic medicine. Aldevron has raised an undisclosed amount in funding from TA Associates. The company has 315 active competitors, including 20 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and KBI Biopharma.
Company Details
Manufacturing plasmid DNA, RNA, proteins, and enzymes for genomic medicine. They offer comprehensive solutions and regulatory support for viral and non-viral vector therapies, simplifying the journey from discovery to commercialization. Services include plasmid design, process development, QC, lentiviral plasmids, nucleases, gRNA, RNA design, LNP encapsulation, and fill/finish. They provide standardized catalog products at research grade, GMP-Source™, and cGMP grade. They support gene therapy, gene-modified cell therapy, gene editing, and RNA vaccines & therapeutics. They offer custom manufacturing workflows, advanced facilities, and certifications to advance therapeutic projects. They provide high-quality biologicals for life science applications, offering contract services and expert support at every stage of development and production.
- Website
- www.aldevron.com/
- Registered Address
- Fargo, North Dakota
Key Metrics
Founded Year
1998
Location
Fargo, United States
Stage
Acquired
Latest Funding Round
Investors
Ranked
18th among 315 active competitors
Employee Count
744 as on Jun 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Danaher (Jun 17, 2021)
Legal entities associated with Aldevron
Aldevron is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Aldevron, Llc CIN: 450451327 , United States, Active | Dec 26, 999 | - | 895 (As on Dec 31, 2022) | - |
Aldevron's acquisition details
Click here to take a look at Aldevron's acquisition in detail
Sign up to download Aldevron's company profile
Aldevron's funding and investors
Aldevron has raised funding over 4 rounds. Its first funding round was on Aug 10, 2007. Its latest funding round was a PE round on Jan 24, 2017 for $*****. 1 investor participated in its latest round. Aldevron has 4 institutional investors.
Here is the list of recent funding rounds of Aldevron:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 24, 2017 | 9740385 | PE | 4499368 | 9219461 | 1561349 | 5230931 |
Sep 15, 2013 | 8055296 | Grant (prize money) | 7970073 | 4340841 | 6122576 | |
Feb 20, 2009 | 1293120 | Grant (prize money) | 4961704 | 1396465 | 2410794 |
View details of Aldevron's funding rounds and investors
Aldevron's founders and board of directors
Founder? Claim ProfileAldevron's employee count trend
Aldevron has 744 employees as of Jun 26. Here is Aldevron's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Aldevron's Competitors and alternates
Top competitors of Aldevron include Anthem Biosciences, Patheon and KBI Biopharma. Here is the list of Top 10 competitors of Aldevron, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Anthem Biosciences 2006, Bengaluru (India), Public | Developer of integrated contract research development and manufacturing services | $35.7M | 77/100 | |
2nd | Patheon 1974, Durham (United States), Acquired | Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 75/100 | |
3rd | KBI Biopharma 1996, Durham (United States), Acquired | Provider of protein formulation, process & cell line development, and cGMP services | $21M | 68/100 | |
4th | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | 66/100 | ||
5th | Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 66/100 | |
6th | Abingdon Health 2008, York (United Kingdom), Public | Developer of immunoassays for diagnostic purposes | $24.1M | 64/100 | |
7th | Panacea Biotec 1984, Ambala (India), Public | Developer of biosimilars, vaccines and natural products | - | 62/100 | |
8th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Aseptic manufacturing CDMO providing fill-finish services for sterile injectables | $16.9M | 59/100 | |
9th | Contract development and manufacturing organization for biologics | - | 58/100 | ||
10th | Piramal Pharma Solutions 1988, Mumbai (India), Unfunded | Contract manufacturer of pharmaceutical products | - | 57/100 | |
18th | Aldevron 1998, Fargo (United States), Acquired | Manufacturing plasmid DNA, RNA, proteins, and enzymes for genomic medicine | - | 53/100 |
Looking for more details on Aldevron's competitors? Click here to see the top ones
Aldevron's Investments and acquisitions
Aldevron has acquired Genovac. Aldevron has not made any investments as of now.Reports related to Aldevron
Here is the latest report on Aldevron's geography:
News related to Aldevron
Media has covered Aldevron for a total of 4 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
•
•
•
US manufactures world’s first mRNA-based personalised CRISPR therapy
BioSpectrum Asia•May 16, 2025•Aldevron, Integrated DNA Technologies
•
•
•
Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade ApplicationsBusiness Wire•Jan 21, 2025•Aldevron
•
Glucotrack Makes Two Senior AppointmentsMedical Product Outsourcing•Sep 06, 2024•GlucoTrack, Aldevron
•
Aldevron, Acuitas Partner to Expand Capabilities in mRNA LNP EncapsulationContract Pharma•May 14, 2024•Acuitas Therapeutic, Aldevron
•
Aldevron Announces Strategic Partnership with Acuitas TherapeuticsBusiness Wire•May 13, 2024•Aldevron, Acuitas Therapeutic
Are you a Founder ?
FAQs about Aldevron
Explore our recently published companies
- Sum Technology - Petaling Jaya based, 2013 founded, Public company
- Rezna - United States based, 2026 founded, Unfunded company
- Moerkantheide - Unfunded company
- Gebaeudereinigung-Jasarov - Unfunded company
- Kosmetikstudio-Windsbach - Unfunded company
- Hammerundneuderth - Unfunded company